Evidence map›Paper›PMID 40612195›Full record

ArticleSage open pediatrics

Congenital Nephrogenic Diabetes Insipidus Secondary to Antenatal Type IVa Bartter Syndrome.

Majd Oweidat, Mohammed Alra'e, Ahmad J Abdallah, Mariam Alqam, Qassam Rae, Kata'eb Talahmeh, Ammar W M Hassouneh

Abstract readCase Reports
In one paragraph

Article in Sage open pediatrics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Majd OweidatCollege of Medicine, Hebron University, Hebron, West Bank, Palestine.ORCID https://orcid.org/0009-0009-2564-5781
Mohammed Alra'eCollege of Medicine, Hebron University, Hebron, West Bank, Palestine.
Ahmad J AbdallahCollege of Medicine, Hebron University, Hebron, West Bank, Palestine.
Mariam AlqamDepartment of Molecular Genetics & Genetic Toxicology, Arab American University, Ramallah, West Bank, Palestine.
Qassam RaeDepartment of Pediatrics, Al-Mezan Specialty Hospital, Hebron, West Bank, Palestine.
Kata'eb TalahmehDepartment of Pediatrics, Al-Ahli Hospital, Hebron, West Bank, Palestine.
Ammar W M HassounehCollege of Medicine, Hebron University, Hebron, West Bank, Palestine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bartter syndrome (BS) is a rare autosomal recessive salt-wasting tubulopathy caused by genetic defects in the thick ascending limb of the loop of Henle. Type IVa BS, presents with severe salt wasting, sensorineural hearing loss, and impaired urinary concentrating ability. We report a 6-month-old female infant with antenatal type IVa BS due to a homozygous BSND variant, who developed secondary congenital nephrogenic diabetes insipidus (NDI), complicating her early clinical course. She presented with failure to thrive, recurrent dehydration, severe electrolyte imbalances, and profound polyuria. Diagnostic evaluation, including genetic testing and a water deprivation test with vasopressin challenge, confirmed impaired urinary concentration of renal origin. Management involved correction of electrolyte disturbances, Indomethacin therapy, and supportive care. This case highlights the importance of recognizing secondary congenital NDI in patients with type IVa BS when polyuria and hypernatremia are more pronounced than typically observed, allowing for earlier intervention and optimized clinical outcomes.

Indexed as

Bartter syndromeBSNDhypernatremiahypokalemianephrogenic diabetes insipiduspolyhydramniossensorineural hearing losstype IVa Bartter syndrome

Identifiers

PMID40612195
PMCPMC12220926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.